Objective:

To investigate whether limiting leukocyte migration into retinal tissue can reduce inflammation in a mouse model of endotoxin-induced uveitis (EIU).

Approach:

• Neutrophil depletion: Researchers assessed CCR2-positive monocyte infiltration and disease measures after depleting neutrophils before inducing EIU.
• PECAM-1 blockade: They treated mice with an anti-PECAM antibody and evaluated leukocyte migration, clinical scores, and retinal histology.

Key Findings:

• Neutrophil depletion increased retinal infiltration by CCR2-positive monocytes at 24 and 72 hours. Histologic measures improved, but clinical scores did not significantly improve.
• Anti-PECAM treatment significantly reduced neutrophil and T-cell transmigration into the retina; imaging showed neutrophils retained within retinal vessels.
• Compared with controls, anti-PECAM-treated mice had significantly lower blinded clinical scores and reduced leukocyte infiltration, edema, and hemorrhage on histology.
• PECAM blockade inhibited approximately 64% of neutrophil transmigration.

Interpretation:

The authors propose that selectively limiting leukocyte entry into ocular tissue could preserve more systemic immune function than broader immunosuppression, but this possibility was not directly tested.

Limitations:

• The study used an acute mouse model of EIU.
• Anti-PECAM was administered before symptoms developed.
• The investigators examined retinal vasculature rather than leukocyte trafficking throughout the uvea.
• Translation of the mechanism into a practical treatment for human uveitis remains undetermined.

Conclusion:

PECAM-1 blockade reduced leukocyte entry and improved clinical and histologic measures in this preclinical EIU model. Further studies are needed to assess its relevance to human uveitis.

Sources:

• Article context provided in the prompt